Solomon Moshkevich Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 15 hours ago
Solomon Moshkevich has an estimated net worth of at least $37.2 million*, as of Jan. 29, 2025. They own 148,203 shares of NTRA stock. They have sold 130,591 shares of NTRA stock since 2021, for an estimated $13.8 million.
Solomon Moshkevich $NTRA SEC Form 4 Insider Trading
Solomon Moshkevich has filed a total of 23 insider trades in $NTRA since 2021. Their most recent trade was a sale of 3 shares, made on Jan 29, 2025. Their largest trade was a sale of 53,489 shares, made on Apr 16, 2024. We estimate that they now own 148,203 shares of $NTRA, worth an estimated $23.4 million.
Insider Trading at $NTRA
There have been a total of 661 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.3 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 400 shares reported by Michael Burkes Brophy (CHIEF FINANCIAL OFFICER), made on Jan 31, 2025.
History of Insider Stock Trades by Solomon Moshkevich
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NTRA
|
Sale | 3 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 4,020 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 1,178 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 62 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
|
NTRA
|
Sale | 24,799 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
|
NTRA
|
Sale | 2,423 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 3 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 2 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 4,858 | Dec 09, 2024 | Dec. 11, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 1,196 | Oct 28, 2024 | Oct. 30, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 256 | Oct 22, 2024 | Oct. 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 294 | Oct 21, 2024 | Oct. 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 1,196 | Jul 29, 2024 | July 31, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 549 | Jul 22, 2024 | July 23, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 1,647 | May 28, 2024 | May 30, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 1,196 | Apr 29, 2024 | May 1, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 531 | Apr 23, 2024 | April 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 26,511 | Apr 16, 2024 | April 17, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 53,489 | Apr 16, 2024 | April 17, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 707 | Mar 28, 2024 | March 29, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 18 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
|
NTRA
|
Sale | 2,227 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
|
NTRA
|
Sale | 3,426 | Jan 29, 2024 | Jan. 30, 2024, 10:02 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.